Literature DB >> 2623003

Day and night locomotor activity effects during administration of (+)-amphetamine.

M T Martin-Iverson1, S D Iversen.   

Abstract

Rats were given continuous subcutaneous amphetamine infusions (0, 2, 6, 10 and 20 mg/kg/day) via osmotic minipumps. The effects of these treatments on the locomotor activity of rats were determined over both light and dark phases of a 12-hr light/dark cycle for 336 consecutive hours. It was observed that tolerance to the locomotor stimulant actions of (+)-amphetamine is both dose- and light/dark cycle-dependent. Locomotor stimulation induced by the two highest doses remained high during both day and night throughout the period of treatment, except for the first few days and nights with the highest dose. Tolerance developed only to the effects of the two lower doses, and only during the day. Effects of the low doses on locomotor activity and on circadian patterns of locomotor activity are roughly similar to those previously observed with continuous administration of a selective dopamine D2 agonist. This behavioral similarity suggests that dopamine released by continuous administration of low doses of (+)-amphetamine may be producing its effects via selective actions on DA D2 receptors in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2623003     DOI: 10.1016/0091-3057(89)90542-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats.

Authors:  Min J Lee; Pamela B Yang; Victor T Wilcox; Keith D Burau; Alan C Swann; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

2.  Time of day influences the voluntary intake and behavioral response to methamphetamine and food reward.

Authors:  Diana R Keith; Carl L Hart; Margaret Robotham; Maliha Tariq; Joseph Le Sauter; Rae Silver
Journal:  Pharmacol Biochem Behav       Date:  2013-05-24       Impact factor: 3.533

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.